APA (7th ed.) Citation

Wang, T., Wang, S., Du, Y., Sun, D., Liu, C., Liu, S., . . . Chen, X. (2024). Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile. Journal of Translational Medicine, 22(1), 1. https://doi.org/10.1186/s12967-023-04710-6

Chicago Style (17th ed.) Citation

Wang, Tao, et al. "Gentulizumab, a Novel Anti-CD47 Antibody with Potent Antitumor Activity and Demonstrates a Favorable Safety Profile." Journal of Translational Medicine 22, no. 1 (2024): 1. https://doi.org/10.1186/s12967-023-04710-6.

MLA (9th ed.) Citation

Wang, Tao, et al. "Gentulizumab, a Novel Anti-CD47 Antibody with Potent Antitumor Activity and Demonstrates a Favorable Safety Profile." Journal of Translational Medicine, vol. 22, no. 1, 2024, p. 1, https://doi.org/10.1186/s12967-023-04710-6.